IMPELLA CP 0048-0003

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2016-05-27 for IMPELLA CP 0048-0003 manufactured by Abiomed Europe, Gmbh (germany).

Event Text Entries

[46133181] The products involved in this event were discarded by the user subsequent to use. The console logs were returned to the manufacturer for analysis. An analysis of the console logs was performed, but was unable to reveal the cause of this issue. An examination of the reported event details revealed that this patient was on pressors, and that he was also exhibiting decreased arterial flow to the leg. With those issues the placement of an impella cp could have exacerbated the reduced flow to the patient's leg. Without the product being returned no evaluation could be done on the repositioning sheath; therefore a definitive root cause for this event could not be determined. It is unclear if this reported issue was related to the impella cp's repositioning sheath or if the issue was the result of the physician's device placement/management, or the patient's condition. The manufacturer will continue to investigate all reasonable obtainable source information, and will provide them on a supplemental medwatch report if they become available. (b)(4). Device discarded by user facility.
Patient Sequence No: 1, Text Type: N, H10


[46133182] The complainant reported that on (b)(6) 2016 a (b)(6) female patient was admitted to the hospital with a total heart block. The physician performed the placement of bare metal stents to the circumflex and the left ascending artery (lad) and repaired a chronic total occlusion. During the 3. 5 hour procedure the patient was successfully supported via the right femoral artery with an impella cp. Following the procedure the patient continued to be supported by the impella pump and was administered pressors and inotropes. The patient was supported with the impella cp for a total of 38 hours. The patient was reported to have did have "deplorable" pulses in the right leg, but that the leg was cool when admitted to the icu. On (b)(6) 2016 the physician found that the patient's right impella leg was still cold and the pump was removed. A fasciotomy was reported to have been performed on the patient's right leg. Following the fasciotomy the patient was reported to be in stable condition.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1220648-2016-00013
MDR Report Key5686403
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2016-05-27
Date of Report2016-04-27
Date of Event2016-04-24
Date Facility Aware2016-04-27
Device Manufacturer Date2015-10-14
Date Added to Maude2016-05-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. WILLIAM BOLT
Manufacturer StreetABIOMED, INC. 22 CHERRY HILL DRIVE
Manufacturer CityDANVERS MA 01923
Manufacturer CountryUS
Manufacturer Postal01923
Manufacturer Phone9786461451
Manufacturer G1ABIOMED EUROPE, GMBH (GERMANY)
Manufacturer StreetNEUEHOFER WEG 3
Manufacturer CityAACHEN, GERMANY 13059, GM
Manufacturer CountryGM
Manufacturer Postal Code13059, GM
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameIMPELLA CP
Generic NameTEMPORARY CARDIAC SUPPORT BLOOD PUMP
Product CodePBL
Date Received2016-05-27
Model NumberIMPELLA CP
Catalog Number0048-0003
Lot Number1209230
Device Expiration Date2017-07-31
OperatorPHYSICIAN
Device AvailabilityN
Device Age6 MO
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABIOMED EUROPE, GMBH (GERMANY)
Manufacturer AddressNEUEHOFER WEG 3 AACHEN, GERMANY 13059, GM GM 13059, GM


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2016-05-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.